FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2895592039> ?p ?o ?g. }

• W2895592039 endingPage "e12756" @default.
• W2895592039 startingPage "e12756" @default.
• W2895592039 abstract "Dermatologic TherapyVolume 32, Issue 1 e12756 Therapeutic Hotline: Letter First case of trastuzumab emtansine-associated hemorrhagic telangiectasias treated with propranolol L. Peuvrel, Corresponding Author L. Peuvrel lucie.peuvrel@chu-nantes.fr orcid.org/0000-0002-4347-915X Department of Dermatology, CHU Nantes, CIC 1413, CRCINA, Université Nantes, Nantes, France Correspondence Lucie Peuvrel, Service de dermatologie, CHU de Nantes, 1 place Alexis Ricordeau, 44000 Nantes, France. Email: lucie.peuvrel@chu-nantes.frSearch for more papers by this authorB. Bregeon, B. Bregeon Department of Dermatology, CHU Nantes, CIC 1413, CRCINA, Université Nantes, Nantes, FranceSearch for more papers by this authorM. Saint-Jean, M. Saint-Jean Department of Dermatology, CHU Nantes, CIC 1413, CRCINA, Université Nantes, Nantes, FranceSearch for more papers by this authorG. Quéreux, G. Quéreux Department of Dermatology, CHU Nantes, CIC 1413, CRCINA, Université Nantes, Nantes, FranceSearch for more papers by this authorC. Frénard, C. Frénard Department of Dermatology, CHU Nantes, CIC 1413, CRCINA, Université Nantes, Nantes, FranceSearch for more papers by this authorA. Khammari, A. Khammari Department of Dermatology, CHU Nantes, CIC 1413, CRCINA, Université Nantes, Nantes, FranceSearch for more papers by this authorA. Wdowik, A. Wdowik Department of Medical Oncology, Centre Hospitalier Bretagne Atlantique, Vannes, FranceSearch for more papers by this authorB. Dréno, B. Dréno Department of Dermatology, CHU Nantes, CIC 1413, CRCINA, Université Nantes, Nantes, FranceSearch for more papers by this authorSupported by GESTIM Nantes group of cutaneous adverse events induced by cancer treatments, Supported by GESTIM Nantes group of cutaneous adverse events induced by cancer treatmentsSearch for more papers by this author L. Peuvrel, Corresponding Author L. Peuvrel lucie.peuvrel@chu-nantes.fr orcid.org/0000-0002-4347-915X Department of Dermatology, CHU Nantes, CIC 1413, CRCINA, Université Nantes, Nantes, France Correspondence Lucie Peuvrel, Service de dermatologie, CHU de Nantes, 1 place Alexis Ricordeau, 44000 Nantes, France. Email: lucie.peuvrel@chu-nantes.frSearch for more papers by this authorB. Bregeon, B. Bregeon Department of Dermatology, CHU Nantes, CIC 1413, CRCINA, Université Nantes, Nantes, FranceSearch for more papers by this authorM. Saint-Jean, M. Saint-Jean Department of Dermatology, CHU Nantes, CIC 1413, CRCINA, Université Nantes, Nantes, FranceSearch for more papers by this authorG. Quéreux, G. Quéreux Department of Dermatology, CHU Nantes, CIC 1413, CRCINA, Université Nantes, Nantes, FranceSearch for more papers by this authorC. Frénard, C. Frénard Department of Dermatology, CHU Nantes, CIC 1413, CRCINA, Université Nantes, Nantes, FranceSearch for more papers by this authorA. Khammari, A. Khammari Department of Dermatology, CHU Nantes, CIC 1413, CRCINA, Université Nantes, Nantes, FranceSearch for more papers by this authorA. Wdowik, A. Wdowik Department of Medical Oncology, Centre Hospitalier Bretagne Atlantique, Vannes, FranceSearch for more papers by this authorB. Dréno, B. Dréno Department of Dermatology, CHU Nantes, CIC 1413, CRCINA, Université Nantes, Nantes, FranceSearch for more papers by this authorSupported by GESTIM Nantes group of cutaneous adverse events induced by cancer treatments, Supported by GESTIM Nantes group of cutaneous adverse events induced by cancer treatmentsSearch for more papers by this author First published: 04 October 2018 https://doi.org/10.1111/dth.12756Citations: 1Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article.Citing Literature Volume32, Issue1January/February 2019e12756 RelatedInformation" @default.
• W2895592039 created "2018-10-12" @default.
• W2895592039 creator A5001247907 @default.
• W2895592039 creator A5002644565 @default.
• W2895592039 creator A5015027319 @default.
• W2895592039 creator A5022797884 @default.
• W2895592039 creator A5055640937 @default.
• W2895592039 creator A5062950383 @default.
• W2895592039 creator A5064458374 @default.
• W2895592039 creator A5090133438 @default.
• W2895592039 date "2018-11-04" @default.
• W2895592039 modified "2023-09-25" @default.
• W2895592039 title "First case of trastuzumab emtansine-associated hemorrhagic telangiectasias treated with propranolol" @default.
• W2895592039 cites W1650731572 @default.
• W2895592039 cites W1965369647 @default.
• W2895592039 cites W2041620759 @default.
• W2895592039 cites W2146929450 @default.
• W2895592039 cites W2154653497 @default.
• W2895592039 cites W2154802260 @default.
• W2895592039 cites W2159967578 @default.
• W2895592039 cites W2334291171 @default.
• W2895592039 doi "https://doi.org/10.1111/dth.12756" @default.
• W2895592039 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30285315" @default.
• W2895592039 hasPublicationYear "2018" @default.
• W2895592039 type Work @default.
• W2895592039 sameAs 2895592039 @default.
• W2895592039 citedByCount "1" @default.
• W2895592039 countsByYear W28955920392019 @default.
• W2895592039 crossrefType "journal-article" @default.
• W2895592039 hasAuthorship W2895592039A5001247907 @default.
• W2895592039 hasAuthorship W2895592039A5002644565 @default.
• W2895592039 hasAuthorship W2895592039A5015027319 @default.
• W2895592039 hasAuthorship W2895592039A5022797884 @default.
• W2895592039 hasAuthorship W2895592039A5055640937 @default.
• W2895592039 hasAuthorship W2895592039A5062950383 @default.
• W2895592039 hasAuthorship W2895592039A5064458374 @default.
• W2895592039 hasAuthorship W2895592039A5090133438 @default.
• W2895592039 hasBestOaLocation W28955920391 @default.
• W2895592039 hasConcept C142362112 @default.
• W2895592039 hasConcept C15708023 @default.
• W2895592039 hasConcept C16005928 @default.
• W2895592039 hasConcept C71924100 @default.
• W2895592039 hasConceptScore W2895592039C142362112 @default.
• W2895592039 hasConceptScore W2895592039C15708023 @default.
• W2895592039 hasConceptScore W2895592039C16005928 @default.
• W2895592039 hasConceptScore W2895592039C71924100 @default.
• W2895592039 hasIssue "1" @default.
• W2895592039 hasLocation W28955920391 @default.
• W2895592039 hasLocation W28955920392 @default.
• W2895592039 hasOpenAccess W2895592039 @default.
• W2895592039 hasPrimaryLocation W28955920391 @default.
• W2895592039 hasRelatedWork W1995515455 @default.
• W2895592039 hasRelatedWork W2039318446 @default.
• W2895592039 hasRelatedWork W2080531066 @default.
• W2895592039 hasRelatedWork W2738981461 @default.
• W2895592039 hasRelatedWork W2748952813 @default.
• W2895592039 hasRelatedWork W2899084033 @default.
• W2895592039 hasRelatedWork W3032375762 @default.
• W2895592039 hasRelatedWork W3108674512 @default.
• W2895592039 hasRelatedWork W4234833016 @default.
• W2895592039 hasRelatedWork W4297184974 @default.
• W2895592039 hasVolume "32" @default.
• W2895592039 isParatext "false" @default.
• W2895592039 isRetracted "false" @default.
• W2895592039 magId "2895592039" @default.
• W2895592039 workType "article" @default.